Chart review of patients with chronic obstructive pulmonary disease, using medical records and artificial intelligence

Not Applicable

• Conditions: Chronic obstructive pulmonary disease; Respiratory

• Registration Number: ISRCTN32473131
• Lead Sponsor: SEPAR (Spanish Society Pneumology and Thoracic Surgery)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-24
• Last Update Posted: 10 February 2020
• Study Completion: 2020-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 2500000

Inclusion Criteria

1. Subjects aged = 35 years old, smokers or former smokers of more than 10 pack-years
2. Had a diagnosis of COPD (a post-bronchodilator ratio forced expiratory volume in the first second [FEV1] / forced vital capacity [FVC] < 0.70, and the presence of respiratory symptoms such as cough, sputum, and dyspnoea)
3. Admitted for ‘‘respiratory disease’’ [respiratory infection or pleural effusion (OR) respiratory failure (OR) right/left heart failure (OR) chronic bronchitis (OR) bronchospasms (AND) [historical diagnosis of COPD (OR) a documented FEV1/FVC < 0.70 in the absence of other obstructive diseases, such as asthma or bronchiolitis]

Exclusion Criteria

Patients with a specific diagnosis upon admission of pulmonary oedema, pneumonia, radiological infiltration, pulmonary embolism, pneumothorax, rib fractures, aspiration, or any other associated respiratory or of non-respiratory condition, such as major cardiopathy with chronic heart failure, extended neoplasia, liver or kidney failure.

Study & Design

• Study Type: Observational
• Study Design: Not specified